Accession Number DE2012-1038048
Title Multimodality Imaging with Silica-Based Targeted Nanoparticle Platforms.
Publication Date Apr 2012
Media Count 26p
Personal Author J. S. Lewis
Abstract To synthesize and characterize a C-Dot silica-based nanoparticle containing 'clickable' groups for the subsequent attachment of targeting moieties (e.g., peptides) and multiple contrast agents (e.g., radionuclides with high specific activity) (1,2). These new constructs will be tested in suitable tumor models in vitro and in vivo to ensure maintenance of target-specificity and high specific activity. Methods: Cy5 dye molecules are cross-linked to a silica precursor which is reacted to form a dye-rich core particle. This core is then encapsulated in a layer of pure silica to create the core-shell C-Dot (Figure 1) (2). A 'click' chemistry approach has been used to functionalize the silica shell with radionuclides conferring high contrast and specific activity (e.g. 64Cu and 89Zr) and peptides for tumor targeting (e.g. cRGD and octreotate) (3). Based on the selective Diels-Alder reaction between tetrazine and norbornene, the reaction is bioorthogonal, highyielding, rapid, and water-compatible. This radiolabeling approach has already been employed successfully with both short peptides (e.g. octreotate) and antibodies (e.g. trastuzumab) as model systems for the ultimate labeling of the nanoparticles (1). Results: PEGylated C-Dots with a Cy5 core and labeled with tetrazine have been synthesized (d = 55 nm, zeta potential = -3 mV) reliably and reproducibly and have been shown to be stable under physiological conditions for up to 1 month. Characterization of the nanoparticles revealed that the immobilized Cy5 dye within the C-Dots exhibited fluorescence intensities over twice that of the fluorophore alone. The nanoparticles were successfully radiolabeled with Cu-64. Efforts toward the conjugation of targeting peptides (e.g. cRGD) are underway. In vitro stability, specificity, and uptake studies as well as in vivo imaging and biodistribution investigations will be presented.
Keywords Antibodies
Chemistry
Detection
Diels-Alder reaction
Diseases
Dyes
Fluorescence
Image processing
In vitro
In vivo
Maintenance
Mortality
Neoplasms
Peptides
Precursor
Radioisotopes
Sensitivity
Silica
Specifications
Stability


 
Source Agency Technical Information Center Oak Ridge Tennessee
NTIS Subject Category 57E - Clinical Medicine
57V - Radiobiology
Corporate Author Sloan-Kettering Inst. for Cancer Research, New York.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1226
Contract Number DE-SC0002184

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader